BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27928113)

  • 1. A Combination of δ-Tocotrienol and Ferulic Acid Synergistically Inhibits Telomerase Activity in DLD-1 Human Colorectal Adenocarcinoma Cells.
    Eitsuka T; Tatewaki N; Nishida H; Nakagawa K; Miyazawa T
    J Nutr Sci Vitaminol (Tokyo); 2016; 62(5):281-287. PubMed ID: 27928113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibition of cancer cell proliferation with a combination of δ-tocotrienol and ferulic acid.
    Eitsuka T; Tatewaki N; Nishida H; Kurata T; Nakagawa K; Miyazawa T
    Biochem Biophys Res Commun; 2014 Oct; 453(3):606-11. PubMed ID: 25285637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol.
    Eitsuka T; Nakagawa K; Miyazawa T
    Biochem Biophys Res Commun; 2006 Sep; 348(1):170-5. PubMed ID: 16875674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. δ-Tocotrienol treatment is more effective against hypoxic tumor cells than normoxic cells: potential implications for cancer therapy.
    Shibata A; Nakagawa K; Tsuduki T; Miyazawa T
    J Nutr Biochem; 2015 Aug; 26(8):832-40. PubMed ID: 25979648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Tocopherol attenuates the cytotoxic effect of delta-tocotrienol in human colorectal adenocarcinoma cells.
    Shibata A; Nakagawa K; Sookwong P; Tsuduki T; Asai A; Miyazawa T
    Biochem Biophys Res Commun; 2010 Jun; 397(2):214-9. PubMed ID: 20493172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells: a dual mechanism approach.
    Eitsuka T; Nakagawa K; Suzuki T; Miyazawa T
    Biochim Biophys Acta; 2005 Oct; 1737(1):1-10. PubMed ID: 16216547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual mechanisms for telomerase inhibition in DLD-1 human colorectal adenocarcinoma cells by polyunsaturated fatty acids.
    Eitsuka T; Nakagawa K; Miyazawa T
    Biofactors; 2004; 21(1-4):19-21. PubMed ID: 15630164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial-dependent anticancer activity of δ-tocotrienol and its synthetic derivatives in HER-2/neu overexpressing breast adenocarcinoma cells.
    Viola V; Ciffolilli S; Legnaioli S; Piroddi M; Betti M; Mazzini F; Pierpaoli E; Provinciali M; Galli F
    Biofactors; 2013; 39(4):485-93. PubMed ID: 23361894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocotrienol inhibits secretion of angiogenic factors from human colorectal adenocarcinoma cells by suppressing hypoxia-inducible factor-1alpha.
    Shibata A; Nakagawa K; Sookwong P; Tsuduki T; Tomita S; Shirakawa H; Komai M; Miyazawa T
    J Nutr; 2008 Nov; 138(11):2136-42. PubMed ID: 18936210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic cytotoxic effects of combined δ-tocotrienol and jerantinine B on human brain and colon cancers.
    Abubakar IB; Lim KH; Kam TS; Loh HS
    J Ethnopharmacol; 2016 May; 184():107-18. PubMed ID: 26947901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of small molecule inhibitors of telomerase activity through transcriptional regulation of hTERT and calcium induction pathway in human lung adenocarcinoma A549 cells.
    Rao YK; Kao TY; Wu MF; Ko JL; Tzeng YM
    Bioorg Med Chem; 2010 Oct; 18(19):6987-94. PubMed ID: 20813535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
    Lei LX; Chen ZD
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Effect of δ-Tocotrienol and γ-Tocopherol on Prostate Cancer Cell Growth.
    Sato C; Kaneko S; Sato A; Virgona N; Namiki K; Yano T
    J Nutr Sci Vitaminol (Tokyo); 2017; 63(5):349-354. PubMed ID: 29225320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Tocotrienol and 6-Gingerol in Combination Synergistically Induce Cytotoxicity and Apoptosis in HT-29 and SW837 Human Colorectal Cancer Cells.
    Yusof KM; Makpol S; Jamal R; Harun R; Mokhtar N; Ngah WZ
    Molecules; 2015 Jun; 20(6):10280-97. PubMed ID: 26046324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta-tocotrienol induces apoptotic cell death via depletion of intracellular squalene in ED40515 cells.
    Yamasaki M; Nishimura M; Sakakibara Y; Suiko M; Morishita K; Nishiyama K
    Food Funct; 2014 Nov; 5(11):2842-9. PubMed ID: 25225850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E suppresses telomerase activity in ovarian cancer cells.
    Bermudez Y; Ahmadi S; Lowell NE; Kruk PA
    Cancer Detect Prev; 2007; 31(2):119-28. PubMed ID: 17335992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
    Liao CH; Hsiao YM; Hsu CP; Lin MY; Wang JC; Huang YL; Ko JL
    Mol Carcinog; 2006 Apr; 45(4):220-9. PubMed ID: 16402390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner.
    Tamakawa RA; Fleisig HB; Wong JM
    Cancer Res; 2010 Nov; 70(21):8684-94. PubMed ID: 20837664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.